Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows revision: v3.5.4, replacing the previous revision v3.5.3, indicating a standard update to the page version.
    Difference
    0.1%
    Check dated 2026-05-15T23:55:04.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a new ClinicalTrials.gov revision version number (from v3.5.2 to v3.5.3). This appears to be a site software/update marker rather than a change to the trial’s information.
    Difference
    0.1%
    Check dated 2026-04-24T16:45:23.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:39:16.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Record history shows new Actual dates added (2026-03-13, 2025-12-05, 2026-03-10) and the revision updated to v3.5.0. Older entries (e.g., 2025-11-05, 2025-11-03, 2025-10) were removed.
    Difference
    0.4%
    Check dated 2026-03-19T23:31:22.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:07:44.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. No user-facing content changes were made.
    Difference
    0.1%
    Check dated 2026-02-12T02:28:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.